Literature DB >> 19259676

Two distinct patterns of ankylosing spondylitis in Moroccan patients.

Laila El Mansouri1, Rachid Bahiri, Fatima Ezzahra Abourazzak, Radouan Abouqal, Najia Hajjaj-Hassouni.   

Abstract

Ankylosing spondylitis (AS) is characterised by a geographic differences in terms of prevalence and clinical expression of the disease. The aim of our study was to describe the actual features of AS in Morocco and we wanted to examine a large population of patients for evidence of phenotypic clustering that could suggest the presence of distinct clinical entities. We investigated 117 patients with a diagnosis of primary AS according to the modified New York criteria. All patients were evaluated according to a standardised data collection form, including demographic variables and disease history with clinical and radiological features. To analyse our data and try to individualise clinical subsets, we applied a two-step cluster analysis using log-likelihood distance measures. Patient's mean age at onset was 25.51 +/- 10.8 year. The mean BASDAI and BASFI score was 33.5 +/- 20.3 and 38.9 +/- 27.5, respectively. Radiographic damage was present in 99.1% of the subjects and radiographic hip involvement in 47.3%. Only 52.6% of patients had been treated with disease modifying antirheumatic drugs. Cluster analysis detected two distinct populations within the data set. Statistically significant differences were found between the two groups particularly concerning activity of the disease, age at onset and the hygienic conditions. Our study revealed that the Moroccan AS was active and severe and suggested that the age at onset and the precarious hygienic level has the greatest capacity to predict activity and severity of the disease.

Entities:  

Mesh:

Year:  2009        PMID: 19259676     DOI: 10.1007/s00296-009-0873-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  40 in total

Review 1.  Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis.

Authors:  Matthew A Brown; Alison M Crane; B Paul Wordsworth
Journal:  Curr Opin Rheumatol       Date:  2002-07       Impact factor: 5.006

2.  Clinical features of adult-onset ankylosing spondylitis in Korean patients: patients with peripheral joint disease (PJD) have less severe spinal disease course than those without PJD.

Authors:  H J Baek; K C Shin; Y J Lee; S W Kang; E B Lee; C D Yoo; Y W Song
Journal:  Rheumatology (Oxford)       Date:  2004-08-17       Impact factor: 7.580

Review 3.  [Ankylosing spondylitis].

Authors:  Abdellah El Maghraoui
Journal:  Presse Med       Date:  2004-11-20       Impact factor: 1.228

4.  Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression.

Authors:  S Brophy; A Calin
Journal:  J Rheumatol       Date:  2001-10       Impact factor: 4.666

5.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

Review 6.  Pathogenesis of ankylosing spondylitis: current concepts.

Authors:  Judith A Smith; Elisabeth Märker-Hermann; Robert A Colbert
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-06       Impact factor: 4.098

7.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

Review 8.  Breakthroughs in genetic studies of ankylosing spondylitis.

Authors:  M A Brown
Journal:  Rheumatology (Oxford)       Date:  2007-11-22       Impact factor: 7.580

Review 9.  Imaging in spondyloarthropathies.

Authors:  Mikayel Grigoryan; Frank W Roemer; Andreas Mohr; Harry K Genant
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

10.  Costs and quality of life of patients with ankylosing spondylitis in Canada.

Authors:  Gisela Kobelt; Patrik Andlin-Sobocki; Walter P Maksymowych
Journal:  J Rheumatol       Date:  2006-02       Impact factor: 4.666

View more
  14 in total

1.  Fatigue in patients with ankylosing spondylitis: prevalence and relationships with disease-specific variables, psychological status, and sleep disturbance.

Authors:  N Aissaoui; S Rostom; J Hakkou; K Berrada Ghziouel; R Bahiri; R Abouqal; N Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2011-04-24       Impact factor: 2.631

2.  Health-related quality of life in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2010-10-31       Impact factor: 2.980

3.  IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes.

Authors:  Sarah Y Lee; Irina A Buhimschi; Antonette T Dulay; Unzila A Ali; Guomao Zhao; Sonya S Abdel-Razeq; Mert O Bahtiyar; Stephen F Thung; Edmund F Funai; Catalin S Buhimschi
Journal:  J Immunol       Date:  2011-01-31       Impact factor: 5.422

4.  Enthesitis and its relationships with disease parameters in Moroccan patients with ankylosing spondylitis.

Authors:  Assia Laatiris; Bouchra Amine; Yousra Ibn Yacoub; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2010-12-15       Impact factor: 2.631

5.  Relationship between diagnosis delay and disease features in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Rachida Bensabbah; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2010-11-26       Impact factor: 2.631

6.  Gender and disease features in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2011-07-28       Impact factor: 2.980

7.  Modulation of amniotic fluid activin-a and inhibin-a in women with preterm premature rupture of the membranes and infection-induced preterm birth.

Authors:  Victor A Rosenberg; Irina A Buhimschi; Antonette T Dulay; Sonya S Abdel-Razeq; Emily A Oliver; Christina M Duzyj; Heather Lipkind; Christian M Pettker; Catalin S Buhimschi
Journal:  Am J Reprod Immunol       Date:  2011-10-13       Impact factor: 3.886

8.  Amniotic fluid angiopoietin-1, angiopoietin-2, and soluble receptor tunica interna endothelial cell kinase-2 levels and regulation in normal pregnancy and intraamniotic inflammation-induced preterm birth.

Authors:  Catalin S Buhimschi; Vineet Bhandari; Antonette T Dulay; Stephen Thung; Sonya S Abdel- Razeq; Victor Rosenberg; Christina S Han; Unzila A Ali; Eduardo Zambrano; Guomao Zhao; Edmund F Funai; Irina A Buhimschi
Journal:  J Clin Endocrinol Metab       Date:  2010-04-21       Impact factor: 5.958

Review 9.  Safety of tumor necrosis factor inhibitors use for rheumatoid arthritis and ankylosing spondylitis in Africa, the Middle East, and Asia: focus on severe infections and tuberculosis.

Authors:  Mohammed Hammoudeh; Abdurhman Alarfaj; Der-Yuan Chen; Hachemi Djoudi; Ehab Youseif; Jian Zhu
Journal:  Clin Rheumatol       Date:  2012-12-15       Impact factor: 2.980

10.  Early diagnosis and treatment of ankylosing spondylitis in Africa and the Middle East.

Authors:  Bahiri Rachid; Bassel El Zorkany; Ehab Youseif; Mohammed Tikly
Journal:  Clin Rheumatol       Date:  2012-08-19       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.